These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17449718)

  • 21. GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release.
    Drabek K; van de Peppel J; Eijken M; van Leeuwen JP
    J Bone Miner Res; 2011 Sep; 26(9):2045-51. PubMed ID: 21638316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin.
    Nakamura M; Matzuk MM; Gerstmayer B; Bosio A; Lauster R; Miyachi Y; Werner S; Paus R
    FASEB J; 2003 Mar; 17(3):497-9. PubMed ID: 12514121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.
    Gordon JA; Tye CE; Sampaio AV; Underhill TM; Hunter GK; Goldberg HA
    Bone; 2007 Sep; 41(3):462-73. PubMed ID: 17572166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-day-treatment of Activin-A leads to transient change in SV-HFO osteoblast gene expression and reduction in matrix mineralization.
    Baroncelli M; Drabek K; Eijken M; van der Eerden BCJ; van de Peppel J; van Leeuwen JPTM
    J Cell Physiol; 2020 May; 235(5):4865-4877. PubMed ID: 31667867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BMP-2 induces the expression of activin betaA and follistatin in vitro.
    Kearns AE; Demay MB
    J Cell Biochem; 2000 Jul; 79(1):80-8. PubMed ID: 10906757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures.
    Addison WN; McKee MD
    Bone; 2010 Apr; 46(4):1100-7. PubMed ID: 20079473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
    de Jong DS; van Zoelen EJ; Bauerschmidt S; Olijve W; Steegenga WT
    J Bone Miner Res; 2002 Dec; 17(12):2119-29. PubMed ID: 12469906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the rat.
    Nagamine T; Imamura T; Ishidou Y; Kato M; Murata F; ten Dijke P; Sakou T
    J Orthop Res; 1998 May; 16(3):314-21. PubMed ID: 9671926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.
    Wang Q; Tabatabaei S; Planz B; Lin CW; Sluss PM
    J Urol; 1999 Apr; 161(4):1378-84. PubMed ID: 10081911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation.
    Lai CF; Cheng SL
    J Bone Miner Res; 2005 Feb; 20(2):330-40. PubMed ID: 15647827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation.
    Woeckel VJ; Eijken M; van de Peppel J; Chiba H; van der Eerden BC; van Leeuwen JP
    J Cell Physiol; 2012 Jun; 227(6):2668-76. PubMed ID: 21898404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activin and follistatin in rat mammary gland.
    Bussmann UA; Lanuza GM; Bussmann LE
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):9-19. PubMed ID: 15223128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
    Ueno A; Miwa Y; Miyoshi K; Horiguchi T; Inoue H; Ruspita I; Abe K; Yamashita K; Hayashi E; Noma T
    J Cell Physiol; 2006 Nov; 209(2):322-32. PubMed ID: 16883596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biglycan modulates osteoblast differentiation and matrix mineralization.
    Parisuthiman D; Mochida Y; Duarte WR; Yamauchi M
    J Bone Miner Res; 2005 Oct; 20(10):1878-86. PubMed ID: 16160746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles.
    Woeckel VJ; Alves RD; Swagemakers SM; Eijken M; Chiba H; van der Eerden BC; van Leeuwen JP
    J Cell Physiol; 2010 Nov; 225(2):593-600. PubMed ID: 20506116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro.
    Wang H; Yoshiko Y; Yamamoto R; Minamizaki T; Kozai K; Tanne K; Aubin JE; Maeda N
    J Bone Miner Res; 2008 Jun; 23(6):939-48. PubMed ID: 18282132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
    Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
    Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization.
    Eijken M; Koedam M; van Driel M; Buurman CJ; Pols HA; van Leeuwen JP
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):87-93. PubMed ID: 16406260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
    Lecanda F; Avioli LV; Cheng SL
    J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.